全球医药塑胶包装市场－按材料、产品类型、地区和竞争格局分類的产业规模、份额、趋势、机会和预测（2021-2031年）

全球医药塑胶包装市场预计将从 2025 年的 796.1 亿美元成长到 2031 年的 1,166.2 亿美元，复合年增长率为 6.57%。

此细分市场涵盖多种聚合物容器产品，包括硬质瓶、管瓶、泡壳包装和预填充式注射器，旨在维持药物稳定性并确保患者安全。市场成长要素是全球慢性病发病率上升和人口老化导致对可靠给药系统的需求不断增长。此外，与传统玻璃相比，塑胶固有的耐用性、轻盈性和更高的设计适应性等优势，也持续推动其在医药物流领域的应用。

儘管行业发展迅速，但由于日益严格的环境审查和塑胶废弃物法规结构，该行业仍面临许多挑战。製造商必须在满足这些永续性要求的同时，遵守严格的安全标准。该行业的规模相当可观；根据柔性包装协会预测，到2024年，医疗和製药应用将占柔性包装需求的约17%。如此庞大的市场份额凸显了该行业在努力平衡医疗需求与不断变化的环境法规时所面临的巨大挑战。

市场驱动因素

生物製药和注射市场的成长正在从根本上改变医药塑胶包装的结构，对高性能封装能力提出了更高的要求。复杂大分子治疗药物和GLP-1减重药物的普及，正促使製造商加速向先进聚合物注射器和自动注射器转型，与传统玻璃相比，这些产品具有更优异的抗破损性和尺寸精度。这种结构性变化直接转化为专业製造商收入的成长。例如，2024年9月，Gerresheimer公司报告称，其塑胶器材部门在前九个月实现了9.2%的有机销售成长，这一业绩主要得益于市场对这些医用塑胶系统的强劲需求。

同时，采用永续和环保的包装解决方案已成为重中之重，迫使整个产业在安全性和循环经济原则之间寻求平衡。各公司正积极采用消费后再生树脂 (PCR) 和轻量化设计，以应对日益严格的环境法规和客户的永续性目标。根据安姆科 (Amcor) 于 2024 年 10 月发布的《2024 年永续发展报告》，该公司已在全球采购超过 22.4 万吨再生材料，以支持其向循环包装组合的转型。这种扩张和对永续性的关注也推动了产业的大规模整合。例如，安姆科宣布将于 2024 年以约 84 亿美元的价格收购贝瑞全球公司 (Berry Worldwide Inc.)，此举将重塑全球医疗包装供应链。

市场挑战

严格的塑胶废弃物法规结构和日益严格的环境审查对全球医药塑胶包装市场的成长构成了重大障碍。这种监管压力迫使製造商将大量资源投入到合规性上，而非扩大产能或创新标准物流，阻碍了市场发展。企业必须应对一系列复杂的新法规，这些法规强制要求可回收性和减少废弃物。为了满足永续性的要求和重要的药品安全标准，企业往往需要对包装材料进行成本高昂的重新设计。检验这些环保替代方案的有效性需要耗费大量资源，造成营运瓶颈，从而有效地延长了药品上市时间，并增加了整体生产成本。

该行业使用的材料数量庞大，凸显了监管的紧迫性和合规的负担。根据医疗保健塑胶回收再利用委员会预测，截至2024年，全球医用塑胶产量预计将在2025年达到480亿磅。如此庞大的数字意味着庞大的环境负担，监管机构正努力减轻这一负担，这也进一步收紧了医药包装产业面临的限制。

市场趋势

在包装上引入防伪序列化技术，以及诸如《药品供应链安全法案》(DSCA) 等严格的追踪要求，正在从根本上改变产业的结构。这一趋势要求在塑胶瓶和管瓶上直接整合二维资料矩阵条码和防篡改功能，以确保端到端供应链的可视性和患者安全。该行业在建立实现这种透明度所需的数位化基础方面取得了显着进展，超越了基本的监管合规，并迈向了​​营运优化。根据医疗保健分销联盟 (HDA) 于 2025 年 8 月发布的一项成员调查，截至 2025 年 6 月初，贸易伙伴之间在产品层面实现准确数据交换的中位数达到 98.5%，表明这些安全通讯协定已被成熟应用。

同时，智能用药依从性追踪技术的整合正在将标准塑胶包装转变为互联的数位资产。透过在标籤和瓶盖中嵌入无线射频识别 (RFID)嵌体和近距离场通讯 (NFC) 标籤，製药公司正在医院环境中实现自动化库存管理和即时药物检验。这种互联性解决了库存可见性和药物完整性的关键挑战，同时简化了临床工作流程。根据 Shriner MediPharm 公司 2025 年 8 月发布的新闻稿，该公司与 KitCheck 的合作已成功追踪超过 3.25 亿单位的注射用急救和麻醉剂，标誌着这些智慧包装系统在工业规模应用方面取得了显着进展。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球医药塑胶包装市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依原料分类（聚丙烯（PP）、聚对苯二甲酸乙二醇酯（PET）、低密度聚乙烯（LDPE）、高密度聚苯乙烯（HDPE）、其他）
  • 依产品类型（固态容器、滴管瓶、鼻喷雾瓶、液体瓶、口腔清洁用品、包装袋、管瓶和安瓿瓶、药筒、注射器、瓶盖和封口件、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美医药塑胶包装市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲医药塑胶包装市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区医药塑胶包装市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲医药塑胶包装市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲医药塑胶包装市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球医药塑胶包装市场：SWOT分析

第十四章 波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Gerresheimer AG
• Amcor PLC
• Berry Plastics Group Inc.
• Aptar Group Inc.
• Berk Company LLC
• Pretium Packaging LLC
• Klockner Pentaplast Group Ltd
• Comar LLC
• Gil Plastic Products Ltd
• Drug Plastics Group Inc

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Pharmaceutical Plastic Packaging Market is projected to expand from USD 79.61 Billion in 2025 to USD 116.62 Billion by 2031, registering a CAGR of 6.57%. This sector encompasses a wide variety of polymeric containment products, such as rigid bottles, vials, blister packs, and prefilled syringes, all engineered to maintain drug stability and guarantee patient safety. The market is primarily driven by the rising global incidence of chronic illnesses and an aging demographic that requires dependable medication delivery systems. Additionally, the inherent benefits of plastics, including their durability, lightweight composition, and superior design adaptability compared to conventional glass, continue to foster their adoption in pharmaceutical logistics.

Despite this growth, the industry faces a major obstacle due to mounting environmental oversight and strict regulatory frameworks regarding plastic waste. Manufacturers are compelled to manage these sustainability demands while strictly adhering to rigorous safety standards. The scale of the sector is significant; according to the Flexible Packaging Association, medical and pharmaceutical applications represented roughly 17% of flexible packaging demand in 2024. This considerable market share highlights the magnitude of the challenge as the industry attempts to balance essential healthcare requirements with evolving environmental mandates.

Market Driver

The growth of the biologics and injectable drug markets is fundamentally transforming the landscape of pharmaceutical plastic packaging, necessitating high-performance containment capabilities. As complex large-molecule therapies and GLP-1 weight-loss drugs gain popularity, manufacturers are increasingly shifting toward advanced polymer syringes and auto-injectors that offer superior break resistance and dimensional precision compared to traditional glass. This structural change is translating directly into revenue increases for specialized producers. For instance, Gerresheimer reported in September 2024 that its Plastics & Devices division achieved 9.2% organic revenue growth for the first nine months of the year, a performance largely attributed to the robust demand for these medical plastic systems.

Concurrently, the adoption of sustainable and eco-friendly packaging solutions has become a critical priority, forcing the industry to balance safety with circular economy principles. Companies are aggressively integrating post-consumer recycled (PCR) resins and lightweight designs to comply with tightening environmental regulations and client sustainability goals. According to Amcor's '2024 Sustainability Report' released in October 2024, the company procured over 224,000 metric tons of recycled material globally to support the transition toward circular packaging portfolios. This drive for scale and sustainability is also triggering major industrial consolidation, evidenced by Amcor's 2024 announcement of a definitive agreement to acquire Berry Global for approximately $8.4 billion, a move set to reshape the global healthcare packaging supply chain.

Market Challenge

Strict regulatory frameworks and intensifying environmental scrutiny regarding plastic waste represent a formidable barrier to the growth of the Global Pharmaceutical Plastic Packaging Market. This regulatory pressure hampers market progress by compelling manufacturers to allocate significant resources toward compliance efforts rather than capacity expansion or innovation in standard logistics. Companies must navigate a complex landscape of new laws demanding recyclability and waste reduction, often necessitating expensive reformulation of packaging materials to ensure they meet both sustainability mandates and critical drug safety standards. The need to validate these eco-friendly alternatives creates operational bottlenecks, effectively slowing the time-to-market for pharmaceutical products and increasing overall production costs.

The immense volume of material used in the sector amplifies the urgency of these regulations, thereby increasing the burden of compliance. According to the Healthcare Plastics Recycling Council, in 2024, global healthcare plastics production was projected to reach 48 billion pounds by 2025. This significant figure illustrates the massive environmental footprint that regulators intend to curtail, consequently tightening the constraints under which the pharmaceutical packaging industry must operate.

Market Trends

The implementation of on-pack anti-counterfeiting serialization is fundamentally reshaping the sector as manufacturers align with rigorous track-and-trace mandates like the Drug Supply Chain Security Act. This trend necessitates the integration of 2D data matrix barcodes and tamper-evident features directly onto plastic bottles and vials to ensure end-to-end supply chain visibility and patient safety. The industry has made substantial progress in establishing the digital infrastructure required for this transparency, moving beyond basic regulatory compliance to operational optimization. As noted by the Healthcare Distribution Alliance in August 2025, a member survey indicated that the median level of accurate data exchange between trading partners at the piece level had reached 98.5% as of early June, signaling a mature adoption of these security protocols.

Simultaneously, the integration of smart adherence tracking technologies is transforming standard plastic packaging into connected digital assets. By embedding Radio Frequency Identification inlays and Near Field Communication tags into labels and closures, pharmaceutical companies are enabling automated inventory management and real-time medication verification in hospital settings. This connectivity addresses critical challenges in stock visibility and drug integrity while streamlining clinical workflows. According to a press release from Schreiner MediPharm in August 2025, the company's collaboration with KitCheck has successfully captured over 325 million units of injectable emergency and anesthetic drugs to date, highlighting the substantial industrial scale of adoption for these intelligent packaging systems.

Key Market Players

• Gerresheimer AG
• Amcor PLC
• Berry Plastics Group Inc.
• Aptar Group Inc.
• Berk Company LLC
• Pretium Packaging LLC
• Klockner Pentaplast Group Ltd
• Comar LLC
• Gil Plastic Products Ltd
• Drug Plastics Group Inc

Report Scope

In this report, the Global Pharmaceutical Plastic Packaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Plastic Packaging Market, By Raw Material

• Polypropylene (PP)
• Polyethylene Terephthalate (PET)
• Low Density Polyethylene (LDPE)
• High Density Polyethylene (HDPE)
• Other

Pharmaceutical Plastic Packaging Market, By Product Type

• Solid Containers
• Dropper Bottles
• Nasal Spray Bottles
• Liquid Bottles
• Oral Care
• Pouches
• Vials and Ampoules
• Cartridges
• Syringes
• Caps and Closures
• Other

Pharmaceutical Plastic Packaging Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Plastic Packaging Market.

Available Customizations:

Global Pharmaceutical Plastic Packaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Plastic Packaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Raw Material (Polypropylene (PP), Polyethylene Terephthalate (PET), Low Density Polyethylene (LDPE), High Density Polyethylene (HDPE), Other)
  • 5.2.2. By Product Type (Solid Containers, Dropper Bottles, Nasal Spray Bottles, Liquid Bottles, Oral Care, Pouches, Vials and Ampoules, Cartridges, Syringes, Caps and Closures, Other)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Pharmaceutical Plastic Packaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Raw Material
  • 6.2.2. By Product Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Plastic Packaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Raw Material
      • 6.3.1.2.2. By Product Type
  • 6.3.2. Canada Pharmaceutical Plastic Packaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Raw Material
      • 6.3.2.2.2. By Product Type
  • 6.3.3. Mexico Pharmaceutical Plastic Packaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Raw Material
      • 6.3.3.2.2. By Product Type

7. Europe Pharmaceutical Plastic Packaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Raw Material
  • 7.2.2. By Product Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pharmaceutical Plastic Packaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Raw Material
      • 7.3.1.2.2. By Product Type
  • 7.3.2. France Pharmaceutical Plastic Packaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Raw Material
      • 7.3.2.2.2. By Product Type
  • 7.3.3. United Kingdom Pharmaceutical Plastic Packaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Raw Material
      • 7.3.3.2.2. By Product Type
  • 7.3.4. Italy Pharmaceutical Plastic Packaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Raw Material
      • 7.3.4.2.2. By Product Type
  • 7.3.5. Spain Pharmaceutical Plastic Packaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Raw Material
      • 7.3.5.2.2. By Product Type

8. Asia Pacific Pharmaceutical Plastic Packaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Raw Material
  • 8.2.2. By Product Type
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Plastic Packaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Raw Material
      • 8.3.1.2.2. By Product Type
  • 8.3.2. India Pharmaceutical Plastic Packaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Raw Material
      • 8.3.2.2.2. By Product Type
  • 8.3.3. Japan Pharmaceutical Plastic Packaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Raw Material
      • 8.3.3.2.2. By Product Type
  • 8.3.4. South Korea Pharmaceutical Plastic Packaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Raw Material
      • 8.3.4.2.2. By Product Type
  • 8.3.5. Australia Pharmaceutical Plastic Packaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Raw Material
      • 8.3.5.2.2. By Product Type

9. Middle East & Africa Pharmaceutical Plastic Packaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Raw Material
  • 9.2.2. By Product Type
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Pharmaceutical Plastic Packaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Raw Material
      • 9.3.1.2.2. By Product Type
  • 9.3.2. UAE Pharmaceutical Plastic Packaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Raw Material
      • 9.3.2.2.2. By Product Type
  • 9.3.3. South Africa Pharmaceutical Plastic Packaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Raw Material
      • 9.3.3.2.2. By Product Type

10. South America Pharmaceutical Plastic Packaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Raw Material
  • 10.2.2. By Product Type
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pharmaceutical Plastic Packaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Raw Material
      • 10.3.1.2.2. By Product Type
  • 10.3.2. Colombia Pharmaceutical Plastic Packaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Raw Material
      • 10.3.2.2.2. By Product Type
  • 10.3.3. Argentina Pharmaceutical Plastic Packaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Raw Material
      • 10.3.3.2.2. By Product Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pharmaceutical Plastic Packaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Gerresheimer AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Amcor PLC
• 15.3. Berry Plastics Group Inc.
• 15.4. Aptar Group Inc.
• 15.5. Berk Company LLC
• 15.6. Pretium Packaging LLC
• 15.7. Klockner Pentaplast Group Ltd
• 15.8. Comar LLC
• 15.9. Gil Plastic Products Ltd
• 15.10. Drug Plastics Group Inc

16. Strategic Recommendations

17. About Us & Disclaimer